SEARCH
New Obesity Pill Shows Promise In Late Stage Trials
The Street
2023-06-27
Views
936
Description
Share / Embed
Download This Video
Report
Novo Nordisk says its obesity pill led to 15% weight loss in late stage trials.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vclip.net//embed/x8m37h8" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
01:17
Weight-Loss Pill Called 'Holy Grail' in Obesity Struggle
00:51
Obesity Pill to Replace Injections
01:20
Is investing in hard asset stocks the same as investing in commodities?
01:57
New Diet Pill For Obesity Epidemic?
00:36
Pfizer Sets Sights on Lucrative Weight Loss Drug Market With Obesity Pill Danuglipron
00:30
Fad Diets Magic Pills Struggle With Obesity Call MyNewSelf Bariatrics In St. Louis
01:04
Scientists Say They've Discovered a Fat Burning Pill to Combat Obesity
01:04
New "holy grail" weight-loss pill to help in the fight against obesity
00:48
Pfizer Halts Development of Obesity and Diabetes Pill Due to Safety Concerns
00:39
Novo Nordisk Shares Pop as New Obesity Drug Candidate Shows Impressive 13.1% Weight Loss in Early Trials
06:38
Investing 101 Stocks, Bonds, 401K, Cash, Portfolios, Asset Allocation, Etc.
02:45
Investing In Rare Assets, RallyRd turns rare collectibles into stocks